Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 cases

Background: Splenic marginal zone lymphoma (SMZL) is a low-grade disorder that regularly presents with peripheral blood (PB) involvement. A precise description of clinical, laboratory features and immunophenotypic characterization of SMZL are still lacking. Here, we reviewed 34 patients presenting w...

Full description

Bibliographic Details
Main Authors: Wafaa Mohammed Al-Anizi, Mohammed Abdul Rassoul Al-Mashta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Iraqi Journal of Hematology
Subjects:
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2017;volume=6;issue=2;spage=84;epage=89;aulast=Al-Anizi
_version_ 1811270568505245696
author Wafaa Mohammed Al-Anizi
Mohammed Abdul Rassoul Al-Mashta
author_facet Wafaa Mohammed Al-Anizi
Mohammed Abdul Rassoul Al-Mashta
author_sort Wafaa Mohammed Al-Anizi
collection DOAJ
description Background: Splenic marginal zone lymphoma (SMZL) is a low-grade disorder that regularly presents with peripheral blood (PB) involvement. A precise description of clinical, laboratory features and immunophenotypic characterization of SMZL are still lacking. Here, we reviewed 34 patients presenting with SMZL to describe the clinical, hematologic features, and flow cytometry immunophenotypic findings of this type of lymphoma at diagnosis. Objectives: The aim of this study is to confirm that SMZL has a specific immunologic profile which enables the hematopathologist and clinician to differentiate this low-grade B-cell lymphoma from other B-cell lymphoproliferative disorder, especially chronic lymphocytic leukemia and hairy cell leukemia, which could sometimes stimulate SMZL morphologically and to emphasize that a correlation of immunophenotypic findings, clinical, and hematologic features of patients plus careful morphological examination of PB and/or bone marrow (BM) aspirate can lead confidently to the correct diagnosis. Materials And Methods: Flow cytometry immunophenotypic findings of 34 cases of SMZL were reviewed. The analysis was performed by BD FACS Calibur™ and FACSCanto II flow cytometers. B lymphocytes were identified according to their Side-Scattered (SSC)/CD19 distribution. A marker was considered positive when expressed in more than 20% of cells above the control. Results: Median age was 60 years, range (35–84 years), both sexes were affected equally. All patients presented with splenomegaly, 71% of patients had absolute lymphocytosis and 88% of patients showed PB involvement. Seventy-four percent of patients had anemia and (53%) of them had thrombocytopenia. Cells from all cases expressed pan B-cell antigens (CD19, CD20), 74% of cases expressed CD79b and Human Leukocyte Antigen – antigen D Related (HLA-DR) expressed in nearly almost all cases (97%). Half of the patients expressed CD11c and SIgD, 41% expressed CD5 and FMC7 while CD25 and CD103 showed positivity in less than 5% of cases. Preferential expression of Kappa light chain was demonstrated, CD10 and CD38, SIgG were negative. Conclusion: SMZL has a distinct immunologic profile which if correlated with morphologic findings of PB or BM aspirates, clinical and hematologic features can help to make the accurate diagnosis and lessens the need of further invasive diagnostic procedure.
first_indexed 2024-04-12T22:04:10Z
format Article
id doaj.art-ac2a3ce889e143d09abc5448dec6314f
institution Directory Open Access Journal
issn 2072-8069
language English
last_indexed 2024-04-12T22:04:10Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Iraqi Journal of Hematology
spelling doaj.art-ac2a3ce889e143d09abc5448dec6314f2022-12-22T03:15:00ZengWolters Kluwer Medknow PublicationsIraqi Journal of Hematology2072-80692017-01-0162848910.4103/ijh.ijh_25_17Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 casesWafaa Mohammed Al-AniziMohammed Abdul Rassoul Al-MashtaBackground: Splenic marginal zone lymphoma (SMZL) is a low-grade disorder that regularly presents with peripheral blood (PB) involvement. A precise description of clinical, laboratory features and immunophenotypic characterization of SMZL are still lacking. Here, we reviewed 34 patients presenting with SMZL to describe the clinical, hematologic features, and flow cytometry immunophenotypic findings of this type of lymphoma at diagnosis. Objectives: The aim of this study is to confirm that SMZL has a specific immunologic profile which enables the hematopathologist and clinician to differentiate this low-grade B-cell lymphoma from other B-cell lymphoproliferative disorder, especially chronic lymphocytic leukemia and hairy cell leukemia, which could sometimes stimulate SMZL morphologically and to emphasize that a correlation of immunophenotypic findings, clinical, and hematologic features of patients plus careful morphological examination of PB and/or bone marrow (BM) aspirate can lead confidently to the correct diagnosis. Materials And Methods: Flow cytometry immunophenotypic findings of 34 cases of SMZL were reviewed. The analysis was performed by BD FACS Calibur™ and FACSCanto II flow cytometers. B lymphocytes were identified according to their Side-Scattered (SSC)/CD19 distribution. A marker was considered positive when expressed in more than 20% of cells above the control. Results: Median age was 60 years, range (35–84 years), both sexes were affected equally. All patients presented with splenomegaly, 71% of patients had absolute lymphocytosis and 88% of patients showed PB involvement. Seventy-four percent of patients had anemia and (53%) of them had thrombocytopenia. Cells from all cases expressed pan B-cell antigens (CD19, CD20), 74% of cases expressed CD79b and Human Leukocyte Antigen – antigen D Related (HLA-DR) expressed in nearly almost all cases (97%). Half of the patients expressed CD11c and SIgD, 41% expressed CD5 and FMC7 while CD25 and CD103 showed positivity in less than 5% of cases. Preferential expression of Kappa light chain was demonstrated, CD10 and CD38, SIgG were negative. Conclusion: SMZL has a distinct immunologic profile which if correlated with morphologic findings of PB or BM aspirates, clinical and hematologic features can help to make the accurate diagnosis and lessens the need of further invasive diagnostic procedure.http://www.ijhonline.org/article.asp?issn=2072-8069;year=2017;volume=6;issue=2;spage=84;epage=89;aulast=Al-AniziClinicalflow cytometerhematologicimmunophenotypingmultiparametersplenic marginal zone lymphoma
spellingShingle Wafaa Mohammed Al-Anizi
Mohammed Abdul Rassoul Al-Mashta
Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 cases
Iraqi Journal of Hematology
Clinical
flow cytometer
hematologic
immunophenotyping
multiparameter
splenic marginal zone lymphoma
title Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 cases
title_full Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 cases
title_fullStr Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 cases
title_full_unstemmed Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 cases
title_short Characteristics of splenic marginal zone lymphoma: Clinical, hematologic, and flow cytometry findings of 34 cases
title_sort characteristics of splenic marginal zone lymphoma clinical hematologic and flow cytometry findings of 34 cases
topic Clinical
flow cytometer
hematologic
immunophenotyping
multiparameter
splenic marginal zone lymphoma
url http://www.ijhonline.org/article.asp?issn=2072-8069;year=2017;volume=6;issue=2;spage=84;epage=89;aulast=Al-Anizi
work_keys_str_mv AT wafaamohammedalanizi characteristicsofsplenicmarginalzonelymphomaclinicalhematologicandflowcytometryfindingsof34cases
AT mohammedabdulrassoulalmashta characteristicsofsplenicmarginalzonelymphomaclinicalhematologicandflowcytometryfindingsof34cases